SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-212544
Filing Date
2020-08-07
Accepted
2020-08-07 08:30:31
Documents
14
Period of Report
2020-08-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d99250d8k.htm   iXBRL 8-K 24316
2 EX-99.1 d99250dex991.htm EX-99.1 13637
6 GRAPHIC g99250g0806142317418.jpg GRAPHIC 4509
  Complete submission text file 0001193125-20-212544.txt   171970

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mack-20200807.xsd EX-101.SCH 3089
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20200807_lab.xml EX-101.LAB 18137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20200807_pre.xml EX-101.PRE 11420
7 EXTRACTED XBRL INSTANCE DOCUMENT d99250d8k_htm.xml XML 3397
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35409 | Film No.: 201083829
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences